BlackRock’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-683,551
| Closed | -$100K | – | 5059 |
|
|
2019
Q4 | $100K | Buy |
683,551
+387
| +0.1% | +$57 | ﹤0.01% | 4388 |
|
|
2019
Q3 | $102K | Buy |
683,164
+1,239
| +0.2% | +$185 | ﹤0.01% | 4390 |
|
|
2019
Q2 | $109K | Sell |
681,925
-96,925
| -12% | -$15.5K | ﹤0.01% | 4403 |
|
|
2019
Q1 | $153K | Sell |
778,850
-5,297
| -0.7% | -$1.04K | ﹤0.01% | 4244 |
|
|
2018
Q4 | $548K | Buy |
784,147
+1,002
| +0.1% | +$700 | ﹤0.01% | 4011 |
|
|
2018
Q3 | $963K | Buy |
783,145
+4,773
| +0.6% | +$5.87K | ﹤0.01% | 3912 |
|
|
2018
Q2 | $863K | Buy |
778,372
+39,493
| +5% | +$43.8K | ﹤0.01% | 3903 |
|
|
2018
Q1 | $1.49M | Sell |
738,879
-2,837
| -0.4% | -$5.7K | ﹤0.01% | 3729 |
|
|
2017
Q4 | $890K | Buy |
741,716
+3,092
| +0.4% | +$3.71K | ﹤0.01% | 3879 |
|
|
2017
Q3 | $931K | Sell |
738,624
-2,081
| -0.3% | -$2.62K | ﹤0.01% | 3866 |
|
|
2017
Q2 | $986K | Sell |
740,705
-1,278,158
| -63% | -$1.7M | ﹤0.01% | 3803 |
|
|
2017
Q1 | $3.75M | Buy |
2,018,863
+2,017,163
| +118,657% | +$3.75M | ﹤0.01% | 3439 |
|
|
2016
Q4 | $9K | Sell |
1,700
-430
| -20% | -$2.28K | ﹤0.01% | 3367 |
|
|
2016
Q3 | $12K | Buy |
2,130
+602
| +39% | +$3.39K | ﹤0.01% | 3316 |
|
|
2016
Q2 | $8K | Buy |
1,528
+1,218
| +393% | +$6.38K | ﹤0.01% | 3416 |
|
|
2016
Q1 | $1K | Buy |
+310
| New | +$1K | ﹤0.01% | 3549 |
|